{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:56:57Z","timestamp":1790693817498,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,7,24]],"date-time":"2013-07-24T00:00:00Z","timestamp":1374624000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s10689-013-9650-y","type":"journal-article","created":{"date-parts":[[2013,7,24]],"date-time":"2013-07-24T07:42:46Z","timestamp":1374651766000},"page":"707-718","source":"Crossref","is-referenced-by-count":55,"title":["Chemoprevention in Lynch syndrome"],"prefix":"10.1007","volume":"12","author":[{"given":"John","family":"Burn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Mathers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Tim","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,24]]},"reference":[{"key":"9650_CR1","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/0092-8674(93)90546-3","volume":"75","author":"R Fishel","year":"1993","unstructured":"Fishel R, Lescoe MK, Rao MRS, Copeland NG, Jenkins NA, Garber J, Kane M, Kolodner R (1993) The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75:1027\u20131038","journal-title":"Cell"},{"key":"9650_CR2","doi-asserted-by":"crossref","unstructured":"Burn J, Gerdes AM, Macrae F, Mecklin JP, Moeslein G, Olschwang S, Eccles D, Evans DG, Maher ER, Bertario L, Bisgaard ML, Dunlop MG, Ho JW, Hodgson SV, Lindblom A, Lubinski J, Morrison PJ, Murday V, Ramesar R, Side L, Scott RJ, Thomas HJ, Vasen HF, Barker G, Crawford G, Elliott F, Movahedi M, Pylvanainen K, Wijnen JT, Fodde R, Lynch HT, Mathers JC, Bishop DT, CAPP2 Investigators (2011) Lancet 378(9809):2081\u20132087","DOI":"10.1016\/S0140-6736(11)61049-0"},{"key":"9650_CR3","first-page":"4399","volume":"48","author":"GA Kune","year":"1988","unstructured":"Kune GA, Kune S, Watson LF (1988) Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study. Cancer Res 48:4399\u20134404","journal-title":"Cancer Res"},{"key":"9650_CR4","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1056\/NEJM199112053252301","volume":"325","author":"MJ Thun","year":"1991","unstructured":"Thun MJ, Namboodiri MM, Heath CW Jr (1991) Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 325:1593\u20131596","journal-title":"N Engl J Med"},{"key":"9650_CR5","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/bjc.1994.181","volume":"69","author":"A Cassidy","year":"1994","unstructured":"Cassidy A, Bingham SA, Cummings JH (1994) Starch intake and colorectal cancer risk: an international comparison. Br J Cancer (Lond) 69:937\u2013942","journal-title":"Br J Cancer (Lond)"},{"key":"9650_CR6","doi-asserted-by":"crossref","first-page":"d6617","DOI":"10.1136\/bmj.d6617","volume":"343","author":"D Aune","year":"2011","unstructured":"Aune D, Chan DS, Lau R, Vieira R, Greenwood DC, Kampman E, Norat T (2011) Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies. BMJ 343:d6617","journal-title":"BMJ"},{"key":"9650_CR7","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/ajcn\/67.1.136","volume":"67","author":"S Hylla","year":"1998","unstructured":"Hylla S, Gostner A, Dusel G, Anger H, Bartram H-P, Christl SU, Kasper H, Scheppach W (1998) Effects of resistant starch on the colon in healthy volunteers: possible implications for cancer prevention. Am J Clin Nutr 67:136\u2013142","journal-title":"Am J Clin Nutr"},{"key":"9650_CR8","doi-asserted-by":"crossref","unstructured":"Grubben MJ, Braak CVD, Essenberg M, Olthof M, Tangerman A, Katan M, Nagengast F (2001) Effect of resistant starch on potential biomarkers for colonic cancer risk in patients with colonic adenomas: a controlled trial. Dig Dis Sci 46:750\u2013756","DOI":"10.1023\/A:1010787931002"},{"key":"9650_CR9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1079\/PNS2002230","volume":"62","author":"EA Williams","year":"2003","unstructured":"Williams EA, Coxhead JM, Mathers JC (2003) Anti-cancer effects of butyrate: use of micro-array technology to investigate mechanisms. Proc Nutr Soc 62:107\u2013115","journal-title":"Proc Nutr Soc"},{"key":"9650_CR10","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1007\/BF02087431","volume":"39","author":"IP Munster van","year":"1994","unstructured":"van Munster IP, Tangerman A, Nagengast FM (1994) Effect of resistant starch on colonic fermentation, bile acid metabolism, and mucosal proliferation. Dig Dis Sci 39:834\u2013842","journal-title":"Dig Dis Sci"},{"key":"9650_CR11","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1158\/1940-6207.CAPR-11-0106","volume":"4","author":"J Burn","year":"2011","unstructured":"Burn J, Bishop DT, Chapman PD, Elliott F, Bertario L, Dunlop MG, Eccles D, Ellis A, Evans DG, Fodde R, Maher ER, Moslein G, Vasen HF, Coaker J, Phillips RK, Bulow S, Mathers JC (2011) A randomized placebo-controlled prevention trial of aspirin and\/or resistant starch in young people with familial adenomatous polyposis. Cancer Prev Res (Phila) 4:655\u2013665","journal-title":"Cancer Prev Res (Phila)"},{"key":"9650_CR12","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1056\/NEJMoa0801297","volume":"359","author":"J Burn","year":"2008","unstructured":"Burn J, Bishop DT, Mecklin J-P, Macrae F, Moslein G, Olschwang S, Bisgaard M-L, Ramesar R, Eccles D, Maher ER, Bertario L, Jarvinen HJ, Lindblom A, Evans DG, Lubinski J, Morrison PJ, Ho JWC, Vasen HFA, Side L, Thomas HJW, Scott RJ, Dunlop M, Barker G, Elliott F, Jass JR, Fodde R, Lynch HT, Mathers JC, CAPP2 Investigators (2008) Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome. N Engl J Med 359:2567\u20132578","journal-title":"N Engl J Med"},{"key":"9650_CR13","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1200\/JCO.2007.13.2795","volume":"26","author":"A Liljegren","year":"2008","unstructured":"Liljegren A, Barker G, Elliott F, Bertario L, Bisgaard ML, Eccles D, Evans G, Macrae F, Maher E, Lindblom A, Rotstein S, Nilsson B, Mecklin JP, Moslein G, Jass J, Fodde R, Mathers J, Burn J, Bishop DT (2008) Prevalence of adenomas and hyperplastic polyps in mismatch repair mutation carriers among CAPP2 participants: report by the colorectal adenoma\/carcinoma prevention programme 2. J Clin Oncol 26:3434\u20133439","journal-title":"J Clin Oncol"},{"key":"9650_CR14","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/jmg.2007.048991","volume":"44","author":"HF Vasen","year":"2007","unstructured":"Vasen HF, Moslein G, Alonso A, Bernstein I, Bertario L, Blanco I, Burn J, Capella G, Engel C, Frayling I, Friedl W, Hes FJ, Hodgson S, Mecklin JP, Moller P, Nagengast F, Parc Y, Renkonen-Sinisalo L, Sampson JR, Stormorken A, Wijnen J (2007) Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J Med Genet 44:353\u2013362","journal-title":"J Med Genet"},{"key":"9650_CR15","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/S1470-2045(12)70475-8","volume":"13","author":"JC Mathers","year":"2012","unstructured":"Mathers JC, Movahedi M, Macrae F, Mecklin JP, Moeslein G, Olschwang S, Eccles D, Evans G, Maher ER, Bertario L, Bisgaard ML, Dunlop M, Ho JW, Hodgson S, Lindblom A, Lubinski J, Morrison PJ, Murday V, Ramesar R, Side L, Scott RJ, Thomas HJ, Vasen H, Gerdes AM, Barker G, Crawford G, Elliott F, Pylvanainen K, Wijnen J, Fodde R, Lynch H, Bishop DT, Burn J, Investigators C (2012) Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet Oncol 13:1242\u20131249","journal-title":"Lancet Oncol"},{"key":"9650_CR16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/01635580903191486","volume":"62","author":"SS Dronamraju","year":"2010","unstructured":"Dronamraju SS, Coxhead JM, Kelly SB, Mathers JC (2010) Differential antineoplastic effects of butyrate in cells with and without a functioning DNA mismatch repair. Nutr Cancer 62:105\u2013115","journal-title":"Nutr Cancer"},{"key":"9650_CR17","doi-asserted-by":"crossref","unstructured":"Din FV, Theodoratou E, Farrington SM, Tenesa A, Barnetson RA, Cetnarskyj R, Stark L, Porteous ME, Campbell H, Dunlop MG (2010) Effect of aspirin and NSAIDs on risk and survival from colorectal cancer. Gut 59:1670\u20131679","DOI":"10.1136\/gut.2009.203000"},{"key":"9650_CR18","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1096\/fj.06-5987com","volume":"20","author":"GM Borthwick","year":"2006","unstructured":"Borthwick GM, Johnson AS, Partington M, Burn J, Wilson R, Arthur HM (2006) Therapeutic levels of aspirin and salicylate directly inhibit a model of angiogenesis through a Cox-independent mechanism. FASEB J 20:2009\u20132016","journal-title":"FASEB J"},{"key":"9650_CR19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1079\/PNS19980030","volume":"57","author":"J Burn","year":"1998","unstructured":"Burn J, Chapman PD, Bishop DT, Mathers J (1998) Diet and cancer prevention: the concerted action polyp prevention (CAPP) studies. Proc Nutr Soc 57:183\u2013186","journal-title":"Proc Nutr Soc"},{"key":"9650_CR20","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1053\/j.gastro.2008.01.015","volume":"134","author":"Y Schwitalle","year":"2008","unstructured":"Schwitalle Y, Kloor M, Eiermann S, Linnebacher M, Kienle P, Knaebel HP, Tariverdian M, Benner A, von Knebel Doeberitz M (2008) Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers. Gastroenterology 134:988\u2013997","journal-title":"Gastroenterology"},{"key":"9650_CR21","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S1470-2045(09)70035-X","volume":"10","author":"J Cuzick","year":"2009","unstructured":"Cuzick J, Otto F, Baron JA, Brown PH, Burn J, Greenwald P, Jankowski J, La Vecchia C, Meyskens F, Senn HJ, Thun M (2009) Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. Lancet Oncol 10:501\u2013507","journal-title":"Lancet Oncol"},{"key":"9650_CR22","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0140-6736(07)60747-8","volume":"369","author":"E Flossmann","year":"2007","unstructured":"Flossmann E, Rothwell PM (2007) Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Lancet 369:1603\u20131613","journal-title":"Lancet"},{"key":"9650_CR23","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(10)61543-7","volume":"376","author":"PM Rothwell","year":"2010","unstructured":"Rothwell PM, Wilson M, Elwin CE, Norrving B, Algra A, Warlow CP, Meade TW (2010) Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet 376:1741\u20131750","journal-title":"Lancet"},{"key":"9650_CR24","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1056\/NEJM199509073331001","volume":"333","author":"E Giovannucci","year":"1995","unstructured":"Giovannucci E, Egan KM, Hunter DJ, Stampfer MJ, Colditz GA, Willett WC, Speizer FE (1995) Aspirin and the risk of colorectal cancer in women. N Engl J Med 333:609\u2013614","journal-title":"N Engl J Med"},{"key":"9650_CR25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(10)62110-1","volume":"377","author":"PM Rothwell","year":"2011","unstructured":"Rothwell PM, Fowkes FG, Belch JF, Ogawa H, Warlow CP, Meade TW (2011) Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet 377:31\u201341","journal-title":"Lancet"},{"key":"9650_CR26","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/ssu.2980110607","volume":"11","author":"HT Lynch","year":"1995","unstructured":"Lynch HT, Smyrk T, Jass JR (1995) Hereditary nonpolyposis colorectal cancer and colonic adenomas: aggressive adenomas? Semin Surg Oncol 11:406\u2013410","journal-title":"Semin Surg Oncol"},{"key":"9650_CR27","doi-asserted-by":"crossref","unstructured":"Vasen HFA, Moslein G, Alonso A et al (2007) Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J Med Genet 44:353\u2013362","DOI":"10.1136\/jmg.2007.048991"},{"key":"9650_CR28","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/jnci\/djn485","volume":"101","author":"BF Cole","year":"2009","unstructured":"Cole BF, Logan RF, Halabi S, Benamouzig R, Sandler RS, Grainge MJ, Chaussade S, Baron JA (2009) Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials. J Natl Cancer Inst 101:256\u2013266","journal-title":"J Natl Cancer Inst"},{"key":"9650_CR29","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0959-8049(02)00041-2","volume":"38","author":"JR Jass","year":"2002","unstructured":"Jass JR, Walsh MD, Barker M, Simms LA, Young J, Leggett BA (2002) Distinction between familial and sporadic forms of colorectal cancer showing DNA microsatellite instability. Eur J Cancer 38:858\u2013866","journal-title":"Eur J Cancer"},{"key":"9650_CR30","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1056\/NEJMoa067208","volume":"356","author":"AT Chan","year":"2007","unstructured":"Chan AT, Ogino S, Fuchs CS (2007) Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N Engl J Med 356:2131\u20132142","journal-title":"N Engl J Med"},{"key":"9650_CR31","doi-asserted-by":"crossref","first-page":"11301","DOI":"10.1073\/pnas.95.19.11301","volume":"95","author":"J Ruschoff","year":"1998","unstructured":"Ruschoff J, Wallinger S, Dietmaier W, Bocker T, Brockhoff G, Hofstadter F, Fishel R (1998) Aspirin suppresses the mutator phenotype associated with hereditary nonpolyposis colorectal cancer by genetic selection. Proc Natl Acad Sci USA 95:11301\u201311306","journal-title":"Proc Natl Acad Sci USA"},{"key":"9650_CR32","doi-asserted-by":"crossref","first-page":"10966","DOI":"10.1158\/0008-5472.CAN-07-2562","volume":"67","author":"MA McIlhatton","year":"2007","unstructured":"McIlhatton MA, Tyler J, Burkholder S, Ruschoff J, Rigas B, Kopelovich L, Fishel R (2007) Nitric oxide-donating aspirin derivatives suppress microsatellite instability in mismatch repair-deficient and hereditary nonpolyposis colorectal cancer cells. Cancer Res 67:10966\u201310975","journal-title":"Cancer Res"},{"key":"9650_CR33","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1158\/1940-6207.CAPR-10-0319","volume":"4","author":"MA McIlhatton","year":"2011","unstructured":"McIlhatton MA, Tyler J, Kerepesi LA, Bocker-Edmonston T, Kucherlapati MH, Edelmann W, Kucherlapati R, Kopelovich L, Fishel R (2011) Aspirin and low-dose nitric oxide-donating aspirin increase life span in a Lynch syndrome mouse model. Cancer Prev Res (Phila) 4:684\u2013693","journal-title":"Cancer Prev Res (Phila)"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-013-9650-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10689-013-9650-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-013-9650-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T01:07:30Z","timestamp":1563498450000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10689-013-9650-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,24]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["9650"],"URL":"https:\/\/doi.org\/10.1007\/s10689-013-9650-y","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,24]]}}}